Explanation of Responses:
|
(
1)
|
The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 23, 2015.
|
(
2)
|
The price recorded in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $106.62 to $107.48, inclusive. The reporting person undertakes to provide ICU Medical, Inc., any security holder of ICU Medical, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4.
|
(
3)
|
The price recorded in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $107.74 to $108.20, inclusive. The reporting person undertakes to provide ICU Medical, Inc., any security holder of ICU Medical, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4.
|
(
4)
|
The price recorded in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $109.12 to $110.03, inclusive. The reporting person undertakes to provide ICU Medical, Inc., any security holder of ICU Medical, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4.
|
(
5)
|
The price recorded in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $110.16 to $110.51, inclusive. The reporting person undertakes to provide ICU Medical, Inc., any security holder of ICU Medical, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4.
|
(
6)
|
The price recorded in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $105.00 to $105.97, inclusive. The reporting person undertakes to provide ICU Medical, Inc., any security holder of ICU Medical, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4.
|
(
7)
|
The price recorded in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $106.03 to $107.02, inclusive. The reporting person undertakes to provide ICU Medical, Inc., any security holder of ICU Medical, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4.
|
(
8)
|
The price recorded in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $107.03 to $108.01, inclusive. The reporting person undertakes to provide ICU Medical, Inc., any security holder of ICU Medical, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4.
|
(
9)
|
The price recorded in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $108.03 to $109.00, inclusive. The reporting person undertakes to provide ICU Medical, Inc., any security holder of ICU Medical, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4.
|
(
10)
|
The price recorded in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $109.03 to $109.62, inclusive. The reporting person undertakes to provide ICU Medical, Inc., any security holder of ICU Medical, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4.
|
(
11)
|
The price recorded in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $110.04 to $110.89, inclusive. The reporting person undertakes to provide ICU Medical, Inc., any security holder of ICU Medical, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4.
|
(
12)
|
Options vest and are exercisable as to 25% of the underlying grant one year after the date of grant and in equal monthly installments thereafter for three additional years.
|
(
13)
|
Transaction is the exercise of a derivative security; see Column 2.
|